Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 30.3% of the common stock of iShares U.S. Indy Rotation Act ETF as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 27.5% beneficial ownership stake in iShares Large Cap Value Active ETF as of December 31, 2024.

BlackRock, Inc. has filed an Amendment No. 7 to Schedule 13G, reporting a beneficial ownership of 40.7% of the Common Stock of ISHARES ESG ADVANCED INVESTM COM as of December 31, 2024.

BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reaffirming its beneficial ownership of 19.5% of the Common Stock of ISHARES MSCI CHINA MULTISECT COM as of December 31, 2024.

BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reaffirming its beneficial ownership of 19.5% of the common stock of ISHARES MSCI CHINA MULTISECT COM.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 9.1% beneficial ownership stake in the iShares Broad USD High Yield Corporate Bond ETF as of December 31, 2024.

BlackRock, Inc. has filed an Amendment No. 14 to its Schedule 13G, reporting a 6.8% beneficial ownership stake in the iShares Core S&P 500 ETF as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 3.1% of the Common Stock of iShares Commodity Curve CARR CL1 as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 13.2% of Crown Holdings Inc.'s common stock as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.98% beneficial ownership stake in Forrester Research Inc. as of December 31, 2024.

BlackRock, Inc. has disclosed an increased beneficial ownership stake of 16.2% in Kennametal Inc. common stock as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a significant beneficial ownership of 17.4% in Lemaitre Vascular Inc. as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 14.1% beneficial ownership stake in Manhattan Associates Inc. as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.9% beneficial ownership stake in Atlas Energy Solutions Inc. as of December 31, 2024.

BlackRock, Inc. has reported a beneficial ownership of 18.1% of Northwestern Energy Group Inc.'s common stock as of December 31, 2024, held for passive investment purposes.

BlackRock, Inc. has reported a beneficial ownership of 14.1% in Radian Group Inc.'s common stock as of December 31, 2024, according to its latest Schedule 13G Amendment No. 8 filing.

BlackRock, Inc. has filed an amended Schedule 13G, reporting its beneficial ownership in Soleno Therapeutics Inc. has decreased to 4.7% as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 16.7% of STAAR Surgical Co.'s common stock as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.8% beneficial ownership stake in Terns Pharmaceuticals, Inc. as of December 31, 2024, held for passive investment purposes.

BlackRock, Inc. has filed an updated Schedule 13G, revealing a 14.0% beneficial ownership stake in RXO Inc.'s common stock as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 4.7% of Sable Offshore Corp's Class A Common Stock as of December 31, 2024.

Investment giant BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.3% beneficial ownership stake in Sunnova Energy International Inc. as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its beneficial ownership of 9.8% of Artesian Resources Corp.'s Class A Common Stock as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.5% beneficial ownership stake in BLACKROCK AAA CLO ETF as of December 31, 2024.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 9.2% beneficial ownership stake in Brookdale Senior Living Inc. as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 12.5% beneficial ownership stake in QuidelOrtho Corp. as of December 31, 2024.

BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, revealing a beneficial ownership of 8.7% of Cross Country Healthcare Inc.'s common stock as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 11.9% of Dynatrace, Inc.'s common stock as of December 31, 2024.

BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a 14.8% beneficial ownership stake in EchoStar Corp's Class A Common Stock as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 9.9% beneficial ownership stake in American Healthcare REIT Inc. as of December 31, 2024.